Amylyx Pharmaceuticals
AMLX
AMLX
119 hedge funds and large institutions have $82.9M invested in Amylyx Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 29 increasing their positions, 44 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
41% less capital invested
Capital invested by funds: $141M → $82.9M (-$58.5M)
86% less call options, than puts
Call options by funds: $546K | Put options by funds: $4.01M
Holders
119
Holding in Top 10
–
Calls
$546K
Puts
$4.01M
Top Buyers
| 1 | +$6.13M | |
| 2 | +$3.62M | |
| 3 | +$2.85M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.3M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.55M |
Top Sellers
| 1 | -$5.27M | |
| 2 | -$3.62M | |
| 3 | -$3.43M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$2.87M |
| 5 |
Morgan Stanley
New York
|
-$2.18M |